...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10
【24h】

TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10

机译:TPGS-壳聚糖作为有效的口服给药系统,可提高辅酶Q10的生物利用度

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to design the chitosan coated TPGS liposome to enhance the bioavailability of Coenzyme Q10 (CoQ10). Optimization of formulation variables for the preparation of the liposome was performed and then three liposomal formulations (TPGS-liposome, TPGS-chitosome, chitosome) were prepared with narrow size distribution and high encapsulation efficiency. All of three liposomal formulations were stable at pH 1.2 and 7.0 for 24 h without any significant drug leakage. Furthermore, chitosan-coated liposomes showed the strong mucoadhesive properties. All the tested liposomal formulations significantly enhanced the cellular uptake of CoQ10 as compared to the untreated drug. Particularly. TPGS-chitosome appeared to be most effective in improving the cellular uptake of CoQ10 in Caco-2 cells (about 30-folds greater than the untreated powder formulation). In oral pharmacokinetic studies, TPGS-chitosome enhanced the systemic exposure of CoQ10 by 3.4 folds as compared to the untreated powder and also displayed the extended drug release profile for up to 24 h in rats. Compared to the untreated powder CoQ10, TPGS-chitosome significantly improved the antioxidant effect of CoQ10 and reduced the intracellular ROS level. In conclusion, TPGS-chitosome significantly enhanced the oral bioavailability of CoQ10 and prolonged drug release profile in rats, suggesting that TPGS-chitosome could be an effective oral delivery platform to improve the oral bioavailability of poorly absorbable drugs. (C) 2014 Elsevier B.V. All rights reserved.
机译:这项研究旨在设计壳聚糖包被的TPGS脂质体,以提高辅酶Q10(CoQ10)的生物利用度。进行用于制备脂质体的制剂变量的优化,然后制备三种脂质体制剂(TPGS-脂质体,TPGS-壳聚糖,壳聚糖),具有窄的尺寸分布和高的包封效率。三种脂质体制剂均在pH 1.2和7.0下稳定24小时,且无明显的药物泄漏。此外,壳聚糖包衣的脂质体显示出强的粘膜粘附特性​​。与未处理的药物相比,所有测试的脂质体制剂均显着提高了CoQ10的细胞摄取。尤其。 TPGS-壳聚糖似乎在改善Caco-2细胞中CoQ10的细胞摄取方面最有效(比未处理的粉末制剂大约30倍)。在口服药代动力学研究中,与未处理的粉末相比,TPGS-壳聚糖将CoQ10的全身暴露提高了3.4倍,并且在大鼠中长达24小时显示出延长的药物释放曲线。与未处理的粉末辅酶Q10相比,TPGS-壳聚糖显着提高了辅酶Q10的抗氧化作用并降低了细胞内ROS水平。总之,TPGS-壳聚糖显着提高了大鼠CoQ10的口服生物利用度并延长了药物的释放曲线,表明TPGS-壳聚糖可能是改善吸收性差的药物的口服生物利用度的有效口服平台。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号